These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Meropenem: evidence of lack of proconvulsive tendency in mice. Patel JB; Giles RE J Antimicrob Chemother; 1989 Sep; 24 Suppl A():307-9. PubMed ID: 2808213 [TBL] [Abstract][Full Text] [Related]
23. Incidence of seizures in pediatric cancer patients treated with imipenem/cilastatin. Karadeniz C; Oğuz A; Canter B; Serdaroğlu A Pediatr Hematol Oncol; 2000; 17(7):585-90. PubMed ID: 11033734 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis. Reed MD; Stern RC; O'Brien CA; Yamashita TS; Myers CM; Blumer JL Antimicrob Agents Chemother; 1985 Apr; 27(4):583-8. PubMed ID: 3859245 [TBL] [Abstract][Full Text] [Related]
25. Neurotoxicity of carbapenem antibacterials. Norrby SR Drug Saf; 1996 Aug; 15(2):87-90. PubMed ID: 8884160 [TBL] [Abstract][Full Text] [Related]
26. [Imipenem/cilastatin: in vitro activity, concentrations in plasma and prostatic adenoma and therapeutic results in patients with complicated urinary tract infections]. Naber KG; Adam D; Bauernfeind A; Hönig E Infection; 1986; 14 Suppl 2():S122-9. PubMed ID: 2428754 [TBL] [Abstract][Full Text] [Related]
27. Imipenem-cilastatin sodium (Primaxin). Med Lett Drugs Ther; 1986 Mar; 28(709):29-31. PubMed ID: 3512968 [No Abstract] [Full Text] [Related]
28. Cross-reactivity and tolerability of imipenem in patients with delayed-type, cell-mediated hypersensitivity to beta-lactams. Schiavino D; Nucera E; Lombardo C; Decinti M; Pascolini L; Altomonte G; Buonomo A; Patriarca G Allergy; 2009 Nov; 64(11):1644-8. PubMed ID: 19392998 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic profile of imipenem/cilastatin in normal volunteers. Drusano GL; Standiford HC Am J Med; 1985 Jun; 78(6A):47-53. PubMed ID: 3859215 [TBL] [Abstract][Full Text] [Related]
35. Effects of beta-lactam antibiotics imipenem/cilastatin and cefodizime on cellular and humoral immune responses in BALB/c-mice. Grochla I; Ko HL; Beuth J; Roszkowski K; Roszkowski W; Pulverer G Zentralbl Bakteriol; 1990 Nov; 274(2):250-8. PubMed ID: 2085374 [TBL] [Abstract][Full Text] [Related]
36. Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin. Calandra GB; Brown KR; Grad LC; Ahonkhai VI; Wang C; Aziz MA Am J Med; 1985 Jun; 78(6A):73-8. PubMed ID: 3859218 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics in healthy subjects of FCE 22101 and its acetoxymethyl ester, FCE 22891: effect of co-administration of imipenem/cilastatin on the renal metabolism of FCE 22101. Norrby SR; Burman LA; Sassella D; Corigli R; Cassinelli G; Franceschi G; Dornbusch K J Antimicrob Chemother; 1990 Mar; 25(3):371-83. PubMed ID: 2338416 [TBL] [Abstract][Full Text] [Related]
38. Relationship between structure and convulsant properties of some beta-lactam antibiotics following intracerebroventricular microinjection in rats. De Sarro A; Ammendola D; Zappala M; Grasso S; De Sarro GB Antimicrob Agents Chemother; 1995 Jan; 39(1):232-7. PubMed ID: 7695312 [TBL] [Abstract][Full Text] [Related]
39. Seizure activity associated with imipenem use: clinical case reports and review of the literature. Leo RJ; Ballow CH DICP; 1991 Apr; 25(4):351-4. PubMed ID: 1926901 [TBL] [Abstract][Full Text] [Related]
40. The Effect of Different Carbapenem Antibiotics (Ertapenem, Imipenem/Cilastatin, and Meropenem) on Serum Valproic Acid Concentrations. Wu CC; Pai TY; Hsiao FY; Shen LJ; Wu FL Ther Drug Monit; 2016 Oct; 38(5):587-92. PubMed ID: 27322166 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]